Comparison between Evoq Remedies IPO and SP Refractories IPO.
Evoq Remedies IPO is a SME Fixed Price IPO proposed to list at BSE SME while SP Refractories IPO is a SME Fixed Price proposed to list at NSE SME.
| Evoq Remedies IPO | SP Refractories IPO | |
|---|---|---|
| Logo |  |  |
| Issue Category | SME | SME |
| Issue Type | IPO | IPO |
| Process Type | Fixed Price | Fixed Price |
| Listing At | BSE SME | NSE SME |
| Lead Managers | Swastika Investmart Ltd. | Aryaman Financial Services Ltd. |
| Registrar | Bigshare Services Pvt.Ltd. | Bigshare Services Pvt.Ltd. |
| Market Maker | Sunflower Broking Pvt.Ltd. | Aryaman Capital Markets Ltd. |
| DRHP | DRHP  | DRHP |
| RHP | RHP | RHP |
| Anchor Investor | ||
| IPO Allotment URL | IPO Allotment URL | IPO Allotment URL |
The total issue size of Evoq Remedies IPO is up to ₹9.23 Cr whereas the issue size of the SP Refractories IPO is up to ₹4.67 Cr. The final issue price of Evoq Remedies IPO is ₹27.00 per share and of SP Refractories IPO is ₹90.00 per share.
| Evoq Remedies IPO | SP Refractories IPO | |
|---|---|---|
| Face Value | ₹10 per share | ₹10 per share |
| Issue Price (Lower) | ||
| Issue Price (Upper) | ||
| Issue Price (Final) | ₹27.00 per share | ₹90.00 per share |
| Discount (Retail) | ₹0.00 per share | ₹0.00 per share |
| Discount (Employee) | ||
| Market Lot Size | 4000 shares | 1600 shares |
| Fresh Issue Size | 34,20,000 shares | 2,68,800 shares |
| Fresh Issue Size (Amount) | up to ₹9.23 Cr | up to ₹2.42 Cr |
| OFS Issue Size | 0 shares | 2,49,600 shares |
| OFS Issue Size (Amount) | up to ₹0.00 Cr | up to ₹2.25 Cr |
| Issue Size Total | 34,20,000 shares | 5,18,400 shares |
| Issue Size Total (Amount) | up to ₹9.23 Cr | up to ₹4.67 Cr |
Evoq Remedies IPO opens on Mar 17, 2022, while SP Refractories IPO opens on Mar 09, 2022. The closing date of Evoq Remedies IPO and SP Refractories IPO is Mar 22, 2022, and Mar 11, 2022, respectively.
| Evoq Remedies IPO | SP Refractories IPO | |
|---|---|---|
| Anchor Bid Date | ||
| Issue Open | Mar 17, 2022 | Mar 09, 2022 |
| Issue Close | Mar 22, 2022 | Mar 11, 2022 |
| Basis Of Allotment (Tentative) | Mar 25, 2022 | Mar 16, 2022 |
| Initiation of Refunds (Tentative) | Mar 28, 2022 | Mar 17, 2022 |
| Credit of Share (Tentative) | Mar 29, 2022 | Mar 21, 2022 |
| Listing date (Tentative) | Mar 30, 2022 | Mar 22, 2022 |
| Anchor Lockin End date 1 | ||
| Anchor Lockin End date 2 |
Evoq Remedies IPO P/E ratio is 33.75, as compared to SP Refractories IPO P/E ratio of 9.94.
| Evoq Remedies IPO | SP Refractories IPO | |||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Financials |
|
| ||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Pre-Issue) | 99.99 | 100 | ||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Post-Issue) | 73.53 | 69.42 | ||||||||||||||||||||||||||||||||||||||||||||||||||||
| P/E Ratio | 33.75 | 9.94 | ||||||||||||||||||||||||||||||||||||||||||||||||||||
| Market Cap | ₹36.72 Cr. | ₹16.11 Cr. | ||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROE | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROCE | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Debt/Equity | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
| EPS | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
| RoNW | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
In the Evoq Remedies IPO Retail Individual Investors (RII) are offered 17,10,000 shares while in SP Refractories IPO retail investors are offered 17,10,000 shares. Qualified Institutional Buyers (QIB) are offered in Evoq Remedies IPO and in SP Refractories IPO.
| Evoq Remedies IPO | SP Refractories IPO | |
|---|---|---|
| Anchor Investor Reserveration | ||
| Market Maker Reserveration | 1,80,000 shares | 28,800 shares |
| QIB | ||
| NII | 17,10,000 shares | 2,59,200 shares |
| RII | 17,10,000 shares | 2,59,200 shares |
| Employee | ||
| Others | ||
| Total | 34,20,000 shares | 5,18,400 shares |
Evoq Remedies IPO subscribed 1.67x in total, whereas SP Refractories IPO subscribed 7.24x.
| Evoq Remedies IPO | SP Refractories IPO | |
|---|---|---|
| QIB (times) | ||
| NII (times) | 0.30x | 5.64x |
| Big NII (times) | ||
| Small NII (times) | ||
| RII (times) | 3.03x | 8.85x |
| Employee (times) | ||
| Other (times) | ||
| Total (times) | 1.67x | 7.24x |
Free Equity Delivery
Flat ₹10 per Trade in Intraday & F&O
